73
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis

, , &
Pages 427-433 | Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Halide E. Temel & Fahrettin Akyuz. (2007) The effects of captopril and losartan on erythrocyte membrane Na+/K+- ATPase activity in experimental diabetes mellitus. Journal of Enzyme Inhibition and Medicinal Chemistry 22:2, pages 213-217.
Read now
Marcin Renke, Leszek Tylicki, Przemyslaw Rutkowski, Klaudiusz Wojnarowski, Wieslawa Lysiak-Szydlowska & Boleslaw Rutkowski. (2005) Low-dose dual blockade of the renin–angiotensin system improves tubular status in non-diabetic proteinuric patients. Scandinavian Journal of Urology and Nephrology 39:6, pages 511-517.
Read now

Articles from other publishers (16)

Zhihao Huo, Huizhen Ye, Peiyi Ye, Guanqing Xiao, Zhe Zhang & Yaozhong Kong. (2021) Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs. PeerJ 9, pages e11661.
Crossref
Mingming Zhao, Rumeng Wang, Yi Yu, Meiying Chang, Sijia Ma, Hanwen Zhang, Hua Qu & Yu Zhang. (2021) Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Mingming Zhao, Hua Qu, Rumeng Wang, Yi Yu, Meiying Chang, Sijia Ma, Hanwen Zhang, Yuejun Wang & Yu Zhang. (2021) Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease. Medicine 100:35, pages e26544.
Crossref
Huizhen Ye, Zhihao Huo, Peiyi Ye, Guanqing Xiao, Zhe Zhang, Chao Xie & Yaozhong Kong. (2020) Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis. PeerJ 8, pages e8575.
Crossref
Deng-feng Geng, Wei-feng Sun, Li Yang, Ge En & Jing-feng Wang. (2013) Antiproteinuric effect of angiotensin receptor blockers in normotensive patients with proteinuria: A meta-analysis of randomized controlled trials. Journal of the Renin-Angiotensin-Aldosterone System 15:1, pages 44-51.
Crossref
Abdul Halim Abdul Gafor, Wan Hazlina Wan Mohamad, Rozita Mohd, Rizna Abdul Cader, Kong Wei Yen, Shamsul Azhar Shah & Norella C. T. Kong. (2014) Antiproteinuric Effect of Sulodexide versus Losartan in Primary Glomerulonephritis. Open Journal of Nephrology 04:02, pages 69-78.
Crossref
Abdul Halim Abdul Gafor, Azrini Abdul Aziz, Rozita Mohd, Rizna Abdul Cader, Kong Wei Yen, Shamsul Azhar Shah & Norella C. T. Kong. (2014) Antiproteinuric Effect of Aliskiren versus Losartan in Primary Glomerulonephritis. Open Journal of Nephrology 04:02, pages 61-68.
Crossref
Yuan-Mei He, Li Feng, Dong-Mei Huo, Zhen-Hua Yang & Yun-Hua Liao. (2013) Enalapril versus losartan for adults with chronic kidney disease: A systematic review and meta-analysis. Nephrology 18:9, pages 605-614.
Crossref
P. Susantitaphong, K. Sewaralthahab, E. M. Balk, S. Eiam-ong, N. E. Madias & B. L. Jaber. (2013) Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-Analysis. American Journal of Hypertension 26:3, pages 424-441.
Crossref
A. Maione, S. D. Navaneethan, G. Graziano, R. Mitchell, D. Johnson, J. F. E. Mann, P. Gao, J. C. Craig, G. Tognoni, V. Perkovic, A. Nicolucci, S. De Cosmo, A. Sasso, O. Lamacchia, M. Cignarelli, V. Maria Manfreda, G. Gentile & G. F. M. Strippoli. (2011) Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials. Nephrology Dialysis Transplantation 26:9, pages 2827-2847.
Crossref
Sheldon W. TobeCatherine M. ClasePeggy GaoMatthew McQueenAnja GrosshennigXingyu WangKoon K. TeoSalim YusufJohannes F.E. Mann. (2011) Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk. Circulation 123:10, pages 1098-1107.
Crossref
Marcin RenkePrzemyslaw Rutkowski, Leszek Tylicki & Boleslaw Rutkowski. (2010) Letter to the Editor: Combination treatment and renal function in patients with chronic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System 11:2, pages 146-147.
Crossref
Fausta Catapano, Paolo Chiodini, Luca De Nicola, Roberto Minutolo, Pasquale Zamboli, Ciro Gallo & Giuseppe Conte. (2008) Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression. American Journal of Kidney Diseases 52:3, pages 475-485.
Crossref
Sofia G. Tsouli, Evagelos N. Liberopoulos, Dimitrios N. KiortsisDimitri P. Mikhailidis & Moses S. Elisaf. (2016) Combined Treatment With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: A Review of the Current Evidence. Journal of Cardiovascular Pharmacology and Therapeutics 11:1, pages 1-15.
Crossref
. (2005) Current World Literature. Current Opinion in Nephrology & Hypertension 14:4, pages 411-421.
Crossref
Leszek Tylicki, Wojciech Larczynski & Bolesław Rutkowski. (2005) Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to Perspectives. Kidney and Blood Pressure Research 28:4, pages 230-242.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.